Influence of the Coronavirus Disease 2019 Pandemic on Patients with ST-Segment Elevation Myocardial Infarction in Taiwan
Table 1
Baseline characteristics, vital signs, and laboratory data.
Variables
Group 1
Group 2
value
February to April 2016–2019 (n = 130)
February to April 2020 (n = 28)
Age (years)
60.9 ± 12.8
59.3 ± 11.9
0.541
Male gender
102 (78.5)
24 (85.7)
0.450
Body mass index (kg/m2)
25.5 ± 4.3
26.0 ± 3.6
0.472
Diabetes mellitus
45 (34.6)
10 (35.7)
1.000
Hypertension
93 (71.5)
18 (64.3)
0.496
Dyslipidemia
110 (84.6)
24 (85.7)
1.000
Current smoking
68 (52.3)
15 (53.6)
1.000
Previous myocardial infarction
21 (16.2)
2 (7.1)
0.374
Systolic blood pressurea
138 ± 35
129 ± 34
0.272
Heart ratea
79 ± 20
78 ± 20
0.825
White blood cell count (k/mm3)a
10.2 (8.5–12.4)
11.0 (8.6–12.8)
0.722
Hemoglobin (g/dL)a
14.6 (13.2–15.5)
14.3 (12.3–15.6)
0.835
Platelet count (k/mm3)a
225 (186–271)
243 (193–294)
0.485
Sugar (mg/dL)a
162 (131–209)
152 (135–227)
0.531
Creatinine (mg/dL)a
1.1 (0.9–1.3)
1.1 (1.0–1.4)
0.298
AST (U/L)a
33 (26–45)
25 (20–47)
0.164
Troponin-I (ng/mL)a
0.06 (0.01–0.53)
0.03 (0.01–0.14)
0.532
Off-hour
96 (73.8)
22 (78.6)
0.848
Killip class II–IVa
45 (34.6)
10 (35.7)
1.000
Data are expressed as mean ± SD or n(%) or median (25th-75th percentile). aThe data were measured upon presentation. . AST, aspartate aminotransferase.
